SCHEMBL7214722

SCHEMBL7214722

Fc1c(F)c(F)c(Cl)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219009 1.00 CES2 (0.38) CES2CES1
SCHEMBL1942159 0.95 CES2 (0.36) CES2CES1
Magnesium SCHEMBL30578300 0.95 CES2 (0.36) CES2CES1
SCHEMBL10589276 0.95 CES2 (0.36) CES2CES1
SCHEMBL4345041 0.95 CES2 (0.33) CES2CES1
SCHEMBL5201867 0.91 CES2 (0.35) CES2CES1
SCHEMBL1756501 0.90 CES2 (0.38) CES2CES1
SCHEMBL8010025 0.88 CES2 (0.33) CES2CES1
SCHEMBL1756525 0.86 CES2 (0.43) CES2CES1
SCHEMBL15758076 0.84 CES2 (0.32) CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303481-A1 PHENYLETHYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF MELANOMA Riley, Patrick Anthony (GB) 2003-04-23 EP disclosed
WO-2002008174-A1 PHENYLETHYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF MELANOMA RILEY PATRICK ANTHONY (GB) 2002-01-31 WO disclosed